New targeted agents in gastroenteropancreatic neuroendocrine tumors.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 2, p. 99, doi. 10.1007/s11523-012-0218-9
- By:
- Publication type:
- Article
Works matching IS 17762596 AND DT 2012 AND VI 7 AND IP 2
Results: 9
1
2
Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
3
Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 2, p. 127, doi. 10.1007/s11523-012-0216-y
- By:
- Publication type:
- Article
4
Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 2, p. 135, doi. 10.1007/s11523-012-0215-z
- By:
- Publication type:
- Article
5
Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 2, p. 145, doi. 10.1007/s11523-012-0214-0
- By:
- Publication type:
- Article
6
Relevance of angiogenesis in neuroendocrine tumors.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 2, p. 93, doi. 10.1007/s11523-012-0217-x
- By:
- Publication type:
- Article
7
Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 2, p. 107, doi. 10.1007/s11523-012-0219-8
- By:
- Publication type:
- Article
8
Sunitinib in pancreatic neuroendocrine tumors.
- Published in:
- Targeted Oncology, 2012, v. 7, n. 2, p. 117, doi. 10.1007/s11523-012-0220-2
- By:
- Publication type:
- Article
9
New treatments of pancreatic neuroendocrine tumors: why using them? How to use them?
- Published in:
- 2012
- By:
- Publication type:
- Editorial